TERT and meningioma: A discrepancy between telomerase hyperactivity and absence of TERT promoter mutation had already been described: Goutagny et al. [33] found TERT promoter mutations in just 15% of grade III meningiomas and telomerase hyperactivity in about 95% of cases.